| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.77B | 11.87B | 12.23B | 14.50B | 12.79B | 10.16B |
| Gross Profit | 1.99B | 2.87B | 3.23B | 4.51B | 4.10B | 2.69B |
| EBITDA | 1.01B | 1.55B | 2.12B | 3.34B | 2.98B | 1.73B |
| Net Income | 184.24M | 401.55M | 852.37M | 1.73B | 1.46B | 725.42M |
Balance Sheet | ||||||
| Total Assets | 18.47B | 18.91B | 19.23B | 20.00B | 18.63B | 16.15B |
| Cash, Cash Equivalents and Short-Term Investments | 4.44B | 5.07B | 5.52B | 5.30B | 5.39B | 4.68B |
| Total Debt | 464.95M | 470.20M | 450.00M | 450.00M | 450.00M | 450.00M |
| Total Liabilities | 3.40B | 3.68B | 3.84B | 4.96B | 4.78B | 3.66B |
| Stockholders Equity | 15.07B | 15.22B | 15.39B | 15.04B | 13.85B | 12.49B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 234.93M | 1.01B | 732.97M | 862.63M | 881.61M |
| Operating Cash Flow | 0.00 | 1.16B | 2.32B | 1.67B | 1.58B | 1.46B |
| Investing Cash Flow | 0.00 | -1.07B | -1.48B | -1.08B | -603.29M | -557.13M |
| Financing Cash Flow | 0.00 | -641.30M | -740.25M | -732.92M | -312.69M | -283.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥28.56B | 13.32 | ― | 2.89% | 6.15% | 2.98% | |
76 Outperform | ¥10.94B | 5.54 | ― | 4.44% | 1.68% | 15.79% | |
75 Outperform | ¥73.27B | 12.98 | ― | 3.12% | 2.78% | -5.32% | |
73 Outperform | ¥19.02B | 18.81 | ― | 2.93% | -1.58% | 12.24% | |
66 Neutral | ¥10.87B | 28.84 | ― | 5.75% | -0.23% | -32.32% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥9.16B | 16.72 | ― | 2.45% | 15.66% | -69.17% |